Top compounds associated with response to EIF4H


Feature Type Standardized
Nominal ANOVA
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.017 0.6
mRNA THZ-2-49 GDSC1000 pan-cancer AAC 0.015 0.6
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.016 0.6
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA narciclasine CTRPv2 pan-cancer AAC 0.017 0.6
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.022 0.6
mRNA Crizotinib GDSC1000 pan-cancer AAC -0.027 0.6
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.027 0.6
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV